Pharmacology II MD0805

DEVELOPMENT
TABLE OF CONTENTS
ADMINISTRATION
INTRODUCTION
LESSON 1
	Section I.  BACKGROUND INFORMATION
		1-1, DEFINITION OF DERMATOLOGICAL AGENTS
		1-2, GENERAL CONSIDERATIONS INVOLVING DERMATOLOGICAL AGENTS
	Section II. THERAPEUTIC CATEGORIES OF DERMATOLOGICAL AGENTS
		1-3, ANTISEBORRHEICS
		1-4, ASTRINGENTS
		1-5, KERATOLYTICS
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 2
	THE HUMAN MUSCULAR SYSTEM
		2-1, BACKGROUND
		2-2, TERMS ASSOCIATED WITH THE HUMAN MUSCULAR SYSTEM
		2-3, PROPERTIES OF MUSCLE TISSUE
		2-4, TYPES OF MUSCLE TISSUE
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 3
	Section 1, GENERAL
		3-1, BACKGROUND
		3-2, DEFINITION OF A MUSCLE RELAXANT
	Section II, THE NEUROMUSCULAR BLOCKING AGENTS
		3-3, MECHANISM OF ACTION
		3-4, USE OF THE NEUROMUSCULAR BLOCKING AGENTS
		3-5, CLASSIFICATION OF THE NEUROMUSCULAR BLOCKING AGENTS
	Section III, CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
		3-6, BACKGROUND
		3-7, EXAMPLES OF CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 4
	Section 1, BACKGROUND
		4-1, INTRODUCTION TO ANALGESIC, ANTI-INFLAMMATORY, AND ANTI-GOUT AGENTS
		4-2, DEFINITIONS
	Section II, ANALGESIC AGENTS
		4-3, BACKGROUND
		4-4, SPECIFIC ANALGESIC AGENTS
	Section III, ANTI-INFLAMMATORY AGENTS
		4-5, BACKGROUND
		4-6, SPECIFIC ANTI-INFLAMMATORY AGENTS
	Section IV. ANTIGOUT AGENTS
		4-7, BACKGROUND
		4-8, DRUGS USED TO TREAT GOUT
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 5
	Section 1, OCCULAR ANATOMY AND PHYSIOLOGY
		5-1, BACKGROUND
		5-2, THE BULBUS OCULI
		5-3, THE ADNEXA
		5-4, DISEASES/CONDITIONS AFFECTING THE EYE
	Section II, AUDITORY ANATOMY AND PHYSIOLOGY
		5-5, BACKGROUND
		5-6, THE EXTERNAL EAR
		5-7, THE MIDDLE EAR
		5-8, THE INTERNAL EAR
		5-9, DISORDERS OR MALFUNCTIONS OF THE EAR
	Section III, ANATOMY AND PHYSIOLOGY OF EQUILIBRIUM (BALANCE)
		5-10, BACKGROUND
		5-11, SACCULUS AND UTRICULUS
		5-12, SEMICIRCULAR DUCTS
		5-13, THE VESTIBULAR NERVE
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 6
	INTRODUCTION
		BACKGROUND
		REVIEW OF THE HUMAN NERVOUS SYSTEM
	THE AUTONOMIC NERVOUS SYSTEM
		INTRODUCTION
		CONTROL OF THE AUTONOMIC NERVOUS SYSTEM
		ORGANIZATION OF THE AUTONOMIC NERVOUS SYSTEM
	THE SYMPATHETIC NERVOUS SYSTEM
		INTRODUCTION TO THE SYMPATHETIC NERVOUS SYSTEM
		PHYSIOLOGY OF THE SYMPATHETIC NERVOUS SYSTEM
		ALPHA AND BETA RECEPTOR SITES
		EFFECTS PRODUCED BY THE SYMPATHETIC NERVOUS SYSTEM
	THE PARASYMPATHETIC NERVOUS SYSTEM
		INTRODUCTION TO THE PARASYMPATHETIC NERVOUS SYSTEM
		PHYSIOLOGY OF THE PARASYMPATHETIC NERVOUS SYSTEM
		EFFECTS PRODUCED BY THE PARASYMPATHETIC NERVOUS SYSTEM
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 7
	ADRENERGIC AGENTS
		7-1, BACKGROUND
		7-2, MECHANISMS OF ACTION OF AGENTS WHICH STIMULATE SYMPATHETIC NERVOUS SYSTEM
		7-3, RECEPTOR SITE THEORY OF ADRENERGIC TRANSMISSION
		7-4, PHARMACOLOGICAL EFFECTS PRODUCED BY ADRENERGIC STIMULATION
		7-5, ADRENERGIC (SYMPATHOHIMETIC) DRUGS
		7-6, SPECIFIC ADRENERGIC (SYMPATHOMIMETIC) AGENTS
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 8
	ADRENERGIC BLOCKING AGENTS
		8-1, INTRODUCTION TO ADRENERGIC BLOCKING AGENTS
		8-2, GENERAL MECHANISMS OF ACTION OF ADRENERGIC BLOCKING AGENTS
		8-3, PRINCIPAL TYPES OF ADRENERGIC RECEPTORS
		8-4, ALPHA ADRENERGIC BLOCKING AGENTS
		8-5, BETA-ADRENERGIC BLOCKING AGENTS
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 9
	CHOLINERGIC AGENTS
		9-1, INTRODUCTION
		9-2, REVIEW OF THE PHYSIOLOGY OF THE CHOLINERGIC PARASYMPATHETIC) NERVOUS SYSTEM
		9-3, CHEMICAL TRANSMISSION IN THE CHOLINERGIC (PARASYMPATHETIC) NERVOUS SYSTEM
		9-4, EFFECTS PRODUCED BY THE CHOLINERGIC NERVOUS SYSTEM
		9-5, THERAPEUTIC USE OF CHOLINERGIC AGENTS
		9-6, TYPES OF CHOLINERGIC AGENTS
	EXERCISES
	SOLUTIONS
	ANNEX
LESSON 10
	CHOLINERGIC BLOCKING AGENTS (ANTICHOLINERGIC AGENTS)
		10-1, INTRODUCTION
		10-2, PHARMACOLOGICAL EFFECTS OF THE CHOLINERGIC BLOCKERS
		10-3, CLINICAL USES OF THE CHOLINERGIC BLOCKERS
		10-4, EXAMPLES OF CHOLINERGIC BLOCKING AGENTS
	EXERCISES
	SOLUTIONS
	ANNEX